Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Linli Luan"'
Autor:
Junwen Deng, Zhongmin Geng, Linli Luan, Dingwen Jiang, Jian Lu, Hanzhong Zhang, Bingguan Chen, Xinlin Liu, Dongming Xing
Publikováno v:
Pharmaceutics, Vol 16, Iss 10, p 1255 (2024)
Background: Trop2 (trophoblast cell-surface antigen 2) is overexpressed in multiple malignancies and is closely associated with poor prognosis, thus positioning it as a promising target for pan-cancer therapies. Despite the approval of Trop2-targeted
Externí odkaz:
https://doaj.org/article/1b98b4bc94424613a825abd00bb2f57f
Autor:
Xinlin Liu, Linli Luan, Xi Liu, Dingwen Jiang, Junwen Deng, Jiazhen Xu, Yang Yuan, Jiyao Xing, Bingguan Chen, Dongming Xing, Haiming Huang
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Human epithelial growth factor receptor-2 (HER2) plays an oncogenic role in numerous tumors, including breast, gastric, and various other solid tumors. While anti-HER2 therapies are approved for the treatment of HER2-positive tumors, a necessity pers
Externí odkaz:
https://doaj.org/article/31cb72e90bb9468aacdde98b705a3c3b
Autor:
Dongping Zhao, Liqin Liu, Xinlin Liu, Jinlei Zhang, Yuqing Yin, Linli Luan, Dingwen Jiang, Xiong Yang, Lei Li, Hualong Xiong, Dongming Xing, Qingbing Zheng, Ningshao Xia, Yuyong Tao, Shaowei Li, Haiming Huang
Publikováno v:
Journal of Nanobiotechnology, Vol 20, Iss 1, Pp 1-15 (2022)
Abstract The major challenge to controlling the COVID pandemic is the rapid mutation rate of the SARS-CoV-2 virus, leading to the escape of the protection of vaccines and most of the neutralizing antibodies to date. Thus, it is essential to develop n
Externí odkaz:
https://doaj.org/article/a231f272f0364fe6b7125d350750c371
Autor:
Dongping Zhao, Liqin Liu, Xinlin Liu, Jinlei Zhang, Yuqing Yin, Linli Luan, Dingwen Jiang, Xiong Yang, Lei Li, Hualong Xiong, Dongming Xing, Qingbing Zheng, Ningshao Xia, Yuyong Tao, Shaowei Li, Haiming Huang
The major challenge to control COVID pandemic is the rapid mutation rate of the SARS-Cov-2 virus, leading to the escape of the protection of vaccines and most of the neutralizing antibodies to date. Thus, it is essential to develop neutralizing antib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6e05160f0f2dd5fd91590edfdc260e6
https://doi.org/10.1101/2022.04.11.487660
https://doi.org/10.1101/2022.04.11.487660
